SMALL CELL LUNG CANCER
Clinical trials for SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost tested to supercharge lung cancer treatment
Disease control TerminatedThis study tested whether adding chest radiation to a standard treatment of immunotherapy and chemotherapy could help people with advanced small-cell lung cancer live longer. It involved 239 adults with this aggressive cancer who had not received prior treatment. The main goal wa…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early cancer drug trial halted after initial safety testing
Disease control TerminatedThis early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New pill tested as potential lifeline for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new oral drug called NKT3447 in adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was later terminated and focused on specif…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer that had stopped responding to hormone therapy, as well as other solid tumors. The trial aimed to see if the drug could slow cancer growth and shrink tumors. The study …
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC